Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Novo-Nordisk ADR repsg 1 B Ord Shs NVO

Healthcare
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:NVO)

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

GlobeNewswire September 24, 2024

Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development

TheNewsWire June 11, 2024

Novo Nordisk launches national Wegovy® campaign, Power of Wegovy®

PR Newswire June 3, 2024

Wegovy® receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesity

PR Newswire March 8, 2024

Novo Nordisk stock hits new high on next-gen weight-loss drug results

Jonathon Brown March 7, 2024

Novo Nordisk stock rallies on Wegovy diabetes drug trial results

Jonathon Brown August 8, 2023

Novo Nordisk takes actions to help protect US patients from unlawful sales of non-FDA approved medicines claiming to contain semaglutide

PR Newswire June 20, 2023

Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024

PR Newswire March 14, 2023

EXL Announces Appointment of Andreas Fibig to Board of Directors

GlobeNewswire January 12, 2023
View More News ››

Opinion & Analysis (NYSE:NVO)

Top First Quarter European ETFs

Benzinga.com  March 31, 2015

A Look At 4 ETFs From The 4 'Least Corrupt' Countries

Benzinga.com  December 4, 2014
View More Opinion ››

Bullboard Posts (NYSE:NVO)

Novo Nordisk's $600 Million Gambit Could Be a Game Changer f

JUST IN: $NVO Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why.2024-09-26 05:40:00 ET Novo...
whytestocks - September 26, 2024

Eli Lilly Just Made Zepbound Even More Appealing. Here's Wha

Just In: $NVO Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.2024-09-05 08:15:00 ET One...
whytestocks - September 5, 2024

Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrive

NEWS: $NVO Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived2024-08-18 14:10:00 ET Over the last couple of years, the...
whytestocks - August 18, 2024

Why Shares of Wegovy Maker Novo Nordisk Are Tumbling Today

Just In: $NVO Why Shares of Wegovy Maker Novo Nordisk Are Tumbling Today2024-08-07 12:23:06 ET The stock's been all the rage since...
whytestocks - August 7, 2024

Using Obesity Drugs? Potential Vision Loss Disorder Linked T

Breaking News: $NVO Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds...
whytestocks - July 3, 2024

Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs

News; $NVO Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares | BenzingaEli Lilly (NYSE:LLY...
whytestocks - January 31, 2024
View more Bullboard ››

Fineqia International Inc.

Fineqia International Inc.

Fineqia International Inc. is a digital asset business that builds and targets investments in early and growth stage ...
View More »